A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis

Clinica Chimica Acta

Volumn 269, Issue 1, 1998, Pages 1-12

  Henderson, Howard ^a,b   Leisegang, Felicity ^a   Hassan, Fahri ^a   Hayden, Michael ^b   Marais, David ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Hypertriglyceridemia; LPL deficiency; LPL gene mutation; Pregnancy

Indexed keywords

LIPOPROTEIN LIPASE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CESAREAN SECTION; DNA DETERMINATION; ENZYME ACTIVITY; EXON; FAMILY; FATALITY; FEMALE; FETUS DISTRESS; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HYPERTRIGLYCERIDEMIA; PANCREATITIS; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL;

ADULT; CATALYSIS; FATAL OUTCOME; FEMALE; GLUTAMIC ACID; HETEROZYGOTE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; LYSINE; PANCREATITIS; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0032509854     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00144-7     Document Type: Article

References (35)

1. Salameh W.A., Mastrogiannis D.S. Maternal hyperlipidemia in pregnancy. Clin Obstet Gynecol. 37:1994;66-77.
2. Iverius P.-H., Brunzell J.D. Relationship between lipoprotein lipase activity and plasma sex steroid levels in obese women. J Clin Invest. 82:1988;1106-1112.
3. Knopp R.H., Warth M.R., Charles D.et al. Lipid metabolism in pregnancy, fat transport to the foetus, and the effects of diabetes. Biol Neonate. 50:1986;297-317.
4. Sorva R., Kuusi T., Dunkel L., Taskinen M.R. Effects of endogenous sex steroids on serum lipoproteins and post-heparin plasma lipolytic enzymes. J Clin Endocrinol Metab. 66:1988;408-413.
5. De Chalain T.M.B., Michell W.L., Berger G.M.B. Hyperlipidemia, pregnancy and pancreatitis. Surg Gynecol Obstet. 167:1988;469-473.
6. Ma Y., Ooi T.C., Liu M.-S.et al. High frequency of mutations in the lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with the apolipoprotein E2 isoform. J Lipid Res. 35:1994;1066-1075.
7. Hsia S.H., Connelly P.W., Hegele R.A. Successful outcome in severe pregnancy associated hyperlipidemia: A case report and literature survey. Am J Med Sci. 309:1995;213-218.
8. Keilson L.M., Calvin P.H., Sprecher D.L., Renfrew R. Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene. Ann Intern Med. 124:1996;425-428.
9. Gall K., Pavicic D., Pavellic J., Audy-Jurkovic S., Pavelic K. PCR amplification of DNA from stained cytological smears. J Clin Pathol. 46:1993;378-379.
10. Provan A.B., Hodges E., Smith A.G., Smith J.L. Use of paraffin wax embedded bone marrow trephine biopsy specimens as a source of archival DNA. J Clin Pathol. 45:1992;763-765.
11. Monsalve M.V., Henderson H.E., Roederer G.et al. A missense mutation at codon 188 of human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency. J Clin Invest. 86:1990;728-734.
12. Chait A., Iverius P.-H., Brunzell J.D. Lipoprotein lipase secretion by human monocyte-derived macrophages. J Clin Invest. 69:1982;490-493.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
14. Sambrook J, Fritsch EF, Maniatis T. "Site-directed mutagenesis of cloned DNA" Molecular cloning: A laboratory manual. In: Ford N, Nolan C, Ferguson M, editors. 2nd ed. New York: Cold Spring Harbour Laboratory Press, 1989;15.3-15.76.
15. Zhang H., Henderson H., Gagne S.E.et al. Common sequence variants of lipoprotein lipase: standardised studies of in vitro expression and catalytic function. Biochim Biophys Acta. 1302:1996;159-166.
16. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha1. J Lipid Res. 31:1990;545-548.
17. Nilsson-Ehle P., Schotz M.C. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res. 17:1976;536-541.
18. Tavangar K., Murata Y., Pedersen M.E.et al. Regulation of lipoprotein lipase in the diabetic rat. J Clin Invest. 90:1992;1672-1678.
19. Iverius P.H., Brunzell J.D. Human adipose tissue lipoprotein lipase: changes with feeding and relation to post-heparin plasma enzyme. Am J Physiol. 249:1985;E107-E114.
20. Petersen J., Fujimoto W.Y., Brunzell J.D. Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. J Lipid Res. 33:1992;1165-1170.
21. Hata A., Robertson M., Emi M., Lalouel J.-M. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res. 18:1990;5407-5411.
22. Elbein S.C., Yeager C., Kwong L.K.et al. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families. J Clin Endocrinol Metab. 79:1994;1450-1456.
23. Yang W.-S., Nevin D.N., Iwasaki L.et al. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Lipid Res. 37:1996;2627-2637.
24. Minnich A., Kessling A., Roy M.et al. Prevalence of LPL alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J Lipid Res. 36:1995;117-124.
25. Wilson D.E., Emi M., Iverius P.-H.et al. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest. 86:1990;735-750.
26. Bijvoet S., Gagne E., Moorjani S.et al. Alterations in plasma lipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res. 37:1996;640-650.
27. Miesenbock G., Holzl B., Foger B.et al. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 91:1993;448-455.
28. Bergeron J., Normand T., Barucha A.et al. Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population. Clin Genet. 41:1992;206-210.
29. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta analysis. J Lipid Res. 33:1992;447-454.
30. Dammerman M., Sankuijl L.A., Halaas J.L., Chung W., Breslow J.L. An apolipoprotein C-III haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci USA. 90:1993;4562-4566.
31. Ito Y., Azrolan N., O'Connell A., Walsh A., Breslow J.L. Hypertriglyceridemia as a result of human apolipoprotein C-III gene expression in transgenic mice. Science. 249:1990;790-793.
32. Aalto-Setala K., Fisher E.A., Chen X.et al. Mechanism of hypertriglyceridemia in human apo C-III transgenic mice: Diminished VLDL fractional catabolic rate associated with increased apoC-III and reduced apoE on the particles. J Clin Invest. 90:1992;1889-1900.
33. Molitch M.E., Oill P., Odell W.D. Massive hyperlipidemia during estrogen therapy. J Am Med Assoc. 227:1974;522-525.
34. Davidoff F., Tishler S., Roshoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. New Engl J Med. 289:1973;552-555.
35. Glueck C.J., Scheel D., Fishback J., Steiner P. Estrogen-induced pancreatitis in patients with previously covert familial Type V hyperlipoproteinemia. Metabolism. 21:1992;657-666.